Parkinson’s disease (PD) is the second most common neurodegenerative disease in the United States after Alzheimer’s disease (AD). To help understand the electrophysiology of these diseases, N27 neuronal cells have been used as an in vitro model. In this study, a flexible graphene-based biosensor design is presented. Biocompatible graphene was manufactured using a liquid-phase exfoliation method and bovine serum albumin (BSA) for further exfoliation. Raman spectroscopy results indicated that the graphene produced was indeed few-layer graphene (FLG) with ID/IGGraphene= 0.11. Inkjet printing of this few-layer graphene ink onto Kapton polyimide (PI) followed by characterization via scanning electron microscopy (SEM) showed an average width of ≈868 µm with a normal thickness of ≈5.20 µm. Neuronal cells were placed on a thermally annealed 3D printed graphene chip. A live–dead cell assay was performed to prove the biosensor biocompatibility. A cell viability of approximately 80% was observed over 96 h, which indicates that annealed graphene on Kapton PI substrate could be used as a neuronal cell biosensor. This research will help us move forward with the study of N27 cell electrophysiology and electrical signaling.

Neonicotinoids are the fastest-growing insecticide accounting for over 25% of the global pesticide market and are capable of controlling a range of pests that damage croplands, home yards/gardens, and golf course greens. However, widespread use has led to nontarget organism decline in pollinators, insects, and birds, while chronic, sublethal effects on humans are still largely unknown. Therefore, there is a need to understand how prevalent neonicotinoids are in the environment as there are currently no commercially available field-deployable sensors capable of measuring neonicotinoid concentrations in surface waters. Herein, we report the first example of a laser-induced graphene (LIG) platform that utilizes electrochemical sensing for neonicotinoid detection. These graphene-based sensors are created through a scalable direct-write laser fabrication process that converts polyimide into LIG, which eliminates the need for chemical synthesis of graphene, ink formulation, masks, stencils, pattern rolls, and postprint annealing commonly associated with other printed graphene sensors. The LIG electrodes were capable of monitoring four major neonicotinoids (CLO, IMD, TMX, and DNT) with low detection limits (CLO, 823 nM; IMD, 384 nM; TMX, 338 nM; and DNT, 682 nM) and a rapid response time (∼10 s) using square-wave voltammetry without chemical/biological functionalization. Interference testing exhibited negligible responses from widely used pesticides including the broad-leaf insecticides parathion, paraoxon, and fipronil, as well as systemic herbicides glyphosate (roundup), atrazine, dicamba, and 2,4-dichlorophenoxyacetic acid. These scalable, graphene-based sensors have the potential for wide-scale mapping of neonicotinoids in watersheds and potential use in numerous electrochemical sensor devices.

Traumatic brain injury and other neurological disorders continue to affect many worldwide and demand further research. It has been shown that electrical signaling and ion channel flow and dynamics are disrupted over the course of a traumatic brain injury as well as over the course of other neurological disorders. However, typical devices used to measure ion flow and electrical signaling from the brain suffer from complexity, high expense, poor spacial and temporal resolution, and low signal to noise ratios. Graphene has emerged as an economical and simple alternative to sensing electrical and ionic signals in a variety of biological situations. This material has emerged as a power material due to its excellent strength, electrical conductivity, and biocompatibility. This review paper focuses on the advantages of the different graphene-based electronic devices and how these devices are being developed into biosensors capable of sensing neuronal ionic and electrical activity and activity from other electrically excitable cells.